Trial intelligence / Profile preview

Fenghua Jieyin suppository for vulvovaginal candidiasis and trichomonas vaginitis

CTR20131052Phase 3Active

Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Fenghua Jieyin in vulvovaginal candidiasis (VVC). Started Nov 2013; status: active.

02

Drugs

Fenghua Jieyin
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on CTR20131052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call